U54HD061221), which is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through collaboration between the Office of Rare Diseases Research (ORDR), the National Center for Advancing Translational Science (NCATS) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and NIH K08DK106453
Overview Epithalon (also called Epitalon) is a synthetic tetrapeptide nasal spray
Many studies have been performed on rats, in lab settings, or on very small sample sizes of humans
Elizabeth Rebello, an anesthesiologist at the University of Texas MD Anderson Cancer Center, was one of the committee members who voted against allowing the four peptides to be compounded, citing unknowns around safety and confusion for the public
10X Concept: Developed with a 10X mindset, aiming to offer notable benefits in a single product